The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 9 rounds in the feed, most often at Other and in Biotech.
Venture capitalmorningside.comRounds from 2011-03-14 to 2026-09-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Synphatec CNS Innovative Drug Developer | Series A Verified against 3 sources | $50M | 2026-09-28 | [ PART ] |
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer. | Series D Verified against 4 of 6 sources |
| $315M |
| 2026-07-15 |
| [ PART ] |
Cognito Therapeutics Cognitotx sells a non-invasive neuroprotective therapy platform designed to evoke brain wave activity to benefit Alzheimer's patients. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $105M | 2026-03-05 | [ LEAD ] |
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer. | Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $112M | 2025-02-03 | [ PART ] |
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer. | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $12.4M | 2022-08-23 | [ LEAD ] |
CellCentric A drug-discovery platform | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $33M | 2020-10-22 | [ LEAD ] |
CRED CRED is a membership platform that rewards trustworthy individuals with financial and lifestyle enhancements, focusing on credit card management and exclusive perks. | Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $25M | 2018-11-26 | [ PART ] |
CellCentric A drug-discovery platform | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $26M | 2018-05-15 | [ LEAD ] |
CellCentric A drug-discovery platform | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2011-03-14 | [ PART ] |